Fundz

Inhibrx, Inc. reported raising $410 Million in an initial SEC Form D filing, from an offering of $410 Million

PRIVATEMay 10, 2018

Amount Raised

$410 Million

$410 Million sold, per SEC Form D (first sale May 10, 2018)

Round Type

Venture

San DiegoBiotechnologyTherapeuticsBiopharma

Quick answer

Inhibrx raised $410 Million in a funding round, dated May 10, 2018. Inhibrx is based in San Diego, California, United States.

How much did Inhibrx raise?
Inhibrx raised $410 Million in a funding round on May 10, 2018.
What does Inhibrx do?
Inhibrx is a clinical-stage biopharmaceutical company focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases.
Where is Inhibrx based and how big is it?
Inhibrx is based in San Diego, California, United States. Fundz records about 110 employees.
Who are the decision-makers at Inhibrx?
Fundz holds 1 contact at Inhibrx, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as Inhibrx that raised within 45 days of this round, from Fundz verified event records.

  • AbSci Corp raised $12M on June 8, 2018.
  • Acurx Pharmaceuticals raised $2.9M on May 31, 2018.
  • Acasti raised $373K on May 25, 2018.
  • Kodiak Sciences raised $30M on May 22, 2018.
  • Aquestive Therapeutics, Inc. raised $9.1M on May 9, 2018.
  • CUREMARK LLC raised $1.7M (Seed) on April 26, 2018.

Who to call at Inhibrx, and when

A new round usually means Inhibrx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Inhibrx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Inhibrx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Inhibrx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Inhibrx

Location

11025 N. TORREY PINES ROAD, SUITE 200

San Diego, California, United States

About

Inhibrx is a clinical-stage biopharmaceutical company focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary protein engineering platforms.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Inhibrx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMark L., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Inhibrx's next move

See what Strategic adds

Inhibrx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.